Literature DB >> 30589608

Evaluating Susceptibility to Pancreatic Cancer: ASCO Clinical Practice Provisional Clinical Opinion Summary.

Elena M Stoffel1, Shannon E McKernin2, Alok A Khorana3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30589608     DOI： 10.1200/JOP.18.00629

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  9 in total

1.  Pancreatic cancer risk to siblings of probands in bilineal cancer settings.

Authors:  Kari G Rabe; Maria A Stevens; Amanda Toledo Hernández; Shruti Chandra; Joleen M Hubbard; Jennifer L Kemppainen; Shounak Majumder; Gloria M Petersen
Journal:  Genet Med       Date:  2022-02-25       Impact factor: 8.864

Review 2.  Cancer Genetic Counseling-Current Practice and Future Challenges.

Authors:  Jaclyn Schienda; Jill Stopfer
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

Review 3.  Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review.

Authors:  Barbara Kenner; Suresh T Chari; David Kelsen; David S Klimstra; Stephen J Pandol; Michael Rosenthal; Anil K Rustgi; James A Taylor; Adam Yala; Noura Abul-Husn; Dana K Andersen; David Bernstein; Søren Brunak; Marcia Irene Canto; Yonina C Eldar; Elliot K Fishman; Julie Fleshman; Vay Liang W Go; Jane M Holt; Bruce Field; Ann Goldberg; William Hoos; Christine Iacobuzio-Donahue; Debiao Li; Graham Lidgard; Anirban Maitra; Lynn M Matrisian; Sung Poblete; Laura Rothschild; Chris Sander; Lawrence H Schwartz; Uri Shalit; Sudhir Srivastava; Brian Wolpin
Journal:  Pancreas       Date:  2021-03-01       Impact factor: 3.243

4.  Examination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer.

Authors:  Cancan Zhou; Nancy Porter; Michael Borges; Christian Gauthier; Lindsey Ferguson; Bo Huang; Neha Nanda; Jin He; Daniel Laheru; Ralph H Hruban; Michael Goggins; Alison P Klein; Nicholas J Roberts
Journal:  Pancreatology       Date:  2021-03-28       Impact factor: 3.977

Review 5.  Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer.

Authors:  Diane Lorenzo; Vinciane Rebours; Frédérique Maire; Maxime Palazzo; Jean-Michel Gonzalez; Marie-Pierre Vullierme; Alain Aubert; Pascal Hammel; Philippe Lévy; Louis de Mestier
Journal:  World J Gastroenterol       Date:  2019-09-14       Impact factor: 5.742

6.  Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer.

Authors:  Jiayu Zhang; Yue Wang; Tiancheng Zhao; Yezhou Li; Leilei Tian; Jinming Zhao; Jingxin Zhang
Journal:  World J Surg Oncol       Date:  2020-02-07       Impact factor: 2.754

Review 7.  Familial Pancreatic Cancer: Current Perspectives.

Authors:  Joan Llach; Sabela Carballal; Leticia Moreira
Journal:  Cancer Manag Res       Date:  2020-01-31       Impact factor: 3.989

8.  Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation.

Authors:  Max M Wattenberg; Daniella Asch; Shun Yu; Peter J O'Dwyer; Susan M Domchek; Katherine L Nathanson; Mark A Rosen; Gregory L Beatty; Evan S Siegelman; Kim A Reiss
Journal:  Br J Cancer       Date:  2019-12-02       Impact factor: 7.640

Review 9.  The Immune Microenvironment in Pancreatic Cancer.

Authors:  Magdalena Huber; Corinna U Brehm; Thomas M Gress; Malte Buchholz; Bilal Alashkar Alhamwe; Elke Pogge von Strandmann; Emily P Slater; Jörg W Bartsch; Christian Bauer; Matthias Lauth
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.